Otros idiomas XTL Biopharmaceuticals Ltd.

Acciones

XTLB

IL0010854979

Mercado cerrado - TEL AVIV STOCK EXCHANGE Otros sitios de cotización 14:49:06 07/07/2024			Varia. Cinco días.	Varia. 1 de enero.
8,1 ^ILa	-1,22 %		+1,25 %	+131,43 %

05/06	XTL Biopharmaceuticals firma un acuerdo para adquirir The Social Proxy	MT
13/05	XTL Biopharmaceuticals Ltd. Resultados del primer trimestre finalizado el 31 de marzo de 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

XTL Biopharmaceuticals : Immediate Report of Meeting	12/06
XTL Biopharmaceuticals : NOTICE OF ANNUAL AND EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JULY 22, 2024 Form 6 K	12/06
XTL Biopharmaceuticals Signs Deal to Acquire The Social Proxy	05/06
XTL Biopharmaceuticals Ltd. announced that it has received $1.5 million in funding	05/06
XTL Biopharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
XTL Biopharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	30/04
Top Premarket Gainers	29/04
XTL Biopharmaceuticals : Report Of Foreign Private Issuer - Form 6-K	02/04
XTL Biopharmaceuticals : Immediate Report of Meeting	21/03
XTL Biopharmaceuticals : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON APRIL 30, 2024 - Form 6-K	21/03
Top Midday Gainers	20/03
XTL Biopharmaceuticals to Acquire The Social Proxy; Shares Soar	20/03
XTL To Aquire The Social Proxy	20/03
XTL Biopharmaceuticals Ltd. announced that it expects to receive $1.5 million in funding	20/03
XTL Biopharmaceuticals Ltd. entered into a binding term sheet to acquire THE SOCIAL PROXY Ltd.	20/03
XTL Biopharmaceuticals Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	15/11
XTL Biopharmaceuticals : Report Of Foreign Private Issuer - Form 6-K	15/11
XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency	20/10/23
XTL Biopharmaceuticals : OPERATING AND FINANCIAL REVIEW AND PROSPECTS (Form 6-K)	25/08/21
XTL Biopharmaceuticals Ltd. Elects Alexander Rabinovitch as Directors	03/08/17

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas XTL Biopharmaceuticals Ltd.

Acciones

XTLB

IL0010854979

Otros idiomas

Filtros